Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21262916rdf:typepubmed:Citationlld:pubmed
pubmed-article:21262916lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0025500lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0040085lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0015249lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0210657lld:lifeskim
pubmed-article:21262916lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:21262916pubmed:issue8lld:pubmed
pubmed-article:21262916pubmed:dateCreated2011-4-18lld:pubmed
pubmed-article:21262916pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:abstractTextThe pemetrexed/platinum agent combination represents the standard of care in first-line treatment for malignant pleural mesothelioma (MPM). However, there are no established indicators of responsiveness that can be used to optimize the treatment. This retrospective study aimed to assess the role of excision repair cross-complementing group-1 (ERCC1) and thymidylate synthase (TS) in tumors, and correlate expression levels and polymorphisms of these key determinants of drug activity with the outcome of MPM patients treated with carboplatin/pemetrexed in first-line setting. Experimental design: Analysis of TS and ERCC1 polymorphisms, mRNA and protein expression was done by PCR and immunohistochemistry [with the H-score (histologic score)] in tumor specimens from 126 MPM patients, including 99 carboplatin-/pemetrexed-treated patients.lld:pubmed
pubmed-article:21262916pubmed:languageenglld:pubmed
pubmed-article:21262916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:citationSubsetIMlld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21262916pubmed:statusMEDLINElld:pubmed
pubmed-article:21262916pubmed:monthAprlld:pubmed
pubmed-article:21262916pubmed:issn1078-0432lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:PetersGodefri...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:RoncalliMassi...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:SantoroArmand...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:DestroAnnarit...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:MencoboniManl...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:CeresoliGiova...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:GiordanoLaura...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:ZucaliPaolo...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:GiovannettiEl...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:TunesiGianniGlld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:BruzzoneAndre...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:SimonelliMatt...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:GianoncelliLe...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:LorenziElenaElld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:ThunnissenEri...lld:pubmed
pubmed-article:21262916pubmed:authorpubmed-author:PerrinoMatteo...lld:pubmed
pubmed-article:21262916pubmed:copyrightInfo©2011 AACR.lld:pubmed
pubmed-article:21262916pubmed:issnTypePrintlld:pubmed
pubmed-article:21262916pubmed:day15lld:pubmed
pubmed-article:21262916pubmed:volume17lld:pubmed
pubmed-article:21262916pubmed:ownerNLMlld:pubmed
pubmed-article:21262916pubmed:authorsCompleteYlld:pubmed
pubmed-article:21262916pubmed:pagination2581-90lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:meshHeadingpubmed-meshheading:21262916...lld:pubmed
pubmed-article:21262916pubmed:year2011lld:pubmed
pubmed-article:21262916pubmed:articleTitleThymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.lld:pubmed
pubmed-article:21262916pubmed:affiliationDepartment of Oncology, Biostatistics Unit, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy. paolo.zucali@humanitas.itlld:pubmed
pubmed-article:21262916pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21262916pubmed:publicationTypeClinical Triallld:pubmed
entrez-gene:2067entrezgene:pubmedpubmed-article:21262916lld:entrezgene
entrez-gene:7298entrezgene:pubmedpubmed-article:21262916lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21262916lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21262916lld:entrezgene